|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Amortization and accretion of marketable securities | |||||
| Stock-based compensation | |||||
| Impairment of right of use asset | |||||
| Loss on disposal of property and equipment | |||||
| Reduction in the carrying amount of right of use assets | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable, accrued liabilities, and operating leases | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from employee stock purchase plan | |||||
| Proceeds from controlled equity offering sales agreement | |||||
| Other | |||||
| Proceeds from controlled equity offering sales agreement, net of commissions | |||||
| Proceeds from follow-on offering, net of underwriting discounts, commissions and offering costs | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash—beginning of year | |||||
| Cash, cash equivalents and restricted cash—end of year | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Right-of-use assets recognized in exchange for operating leases | |||||
| Property and equipment included in accrued expense and accounts payable | |||||
Loading...